U.S. Interventional Radiology Market Expected to Witness a Sustainable Growth

1. U.S. Interventional Radiology Market

2. Interventional radiology is a technique that provides minimally invasive image-guided diagnosis and treatment. It is widely performed for both diagnostic and therapeutic procedures and uses radiological image guidance such as intra-vascular ultrasound, X-ray fluoroscopy, ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI). Interventional radiology techniques guide catheters and other small instruments inside the body and diagnose the site of concern to treat a variety of medical disorders without invasive surgery. In addition, interventional radiology reduces pain, risk, and recovery time in comparison to open surgery owing to its less invasive nature, and thus is increasingly being used for various disease diagnosis. The essential skills required for the interventional radiologist are in diagnostic image interpretation, operation of needles, and the use of fine catheter tubes & wires to navigate around the body under imaging control. Get Sample Report

3. The U.S. interventional radiology market is expected to witness significant growth during the forecast period due to factors such as increase in preference for minimally invasive imaging guided procedures and rise in prevalence of chronic diseases such as cancer, blood vessel diseases, and others. In addition, introduction of novel technologies such as fractional flow reserve, thrombectomy technologies, and intra-vascular ultrasound technology is expected to drive the growth of the U.S interventional radiology market. However, implementation of stringent regulatory procedures for approval of interventional radiology devices and their high cost are the major factors anticipated to restrain the market growth. On the contrary, recent advancements and increase in applications & launches of interventional radiology accessories in the U.S. are projected to offer remunerative opportunities for market expansion during the forecast period.

4. For instance, Philips launched a new IntraSight interventional application-based platform, which offers the fractional flow reserve (FFR) and intravascular ultrasound (IVUS) for image-guided treatments of the heart and peripheral blood vessels. In addition, Embolx received an FDA approval for the next-generation sniper balloon occlusion microcatheter, which is available in three lengths 110, 130, and 150 cm and enables the advanced navigation through radial arterial access and complex vascular structures. Furthermore, ion endoluminal system provided by the Intuitive Surgical Inc. received the U.S. Food and Drug Administration (FDA) clearance that enables minimally invasive biopsy in peripheral lung.

5. KEY BENEFITS FOR STAKEHOLDERS • This report provides a detailed quantitative analysis of the current interventional radiology market trends and future estimations from 2019 to 2026, which assist to identify the prevailing opportunities. • A comprehensive analysis of the factors that drive and restrain the growth of the global interventional radiology market is provided. • Region-wise and country-wise market conditions are comprehensively analyzed in this report. • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

6. The key players operating in the U.S. interventional-radiology market include GENERAL ELECTRIC, Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi Medical Corporation, Carestream Health, EsaoteSpA, Hologic, Inc., Shimadzu Corporation and Samsung Medison Co., Ltd., and Siemens Healthcare Diagnostics, Inc. Other players profiled in the report are Embolx, Inc., Cardinal Health, B. Braun Melsungen AG, BD, Stryker, and Cook.